McGowan, Josephine C.
Hill, Collin
Mastrodonato, Alessia
LaGamma, Christina T.
Kitayev, Alexander
Brachman, Rebecca A.
Narain, Niven R.
Kiebish, Michael A.
Denny, Christine A.
Article History
Received: 5 June 2017
Revised: 12 February 2018
Accepted: 26 February 2018
First Online: 29 March 2018
Conflict of interest
: AM and CTL reported no biomedical financial interests or potential conflicts of interests. CH, AK, NRN, and MAK are employees of BERG LLC and own stock. NRN is a founder of BERG. JCM, RAB, and CAD are named on non-provisional patent applications for the prophylactic use of ketamine against stress-related psychiatric disorders.